Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

September 17, 2018 updated by: Bo Wang,MD
Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.

Study Overview

Detailed Description

The patients with papillary thyroid microcarcinoma were included according to the inclusive criteria and randomly divided them into two groups (foot-control exhaust group and direct exhaust group). The foot-control exhaust group used the foot-control exhaust method by the way of adjustable Pressure to intermittent exhaust, while direct exhaust group exhaust through the Trocar hole. Comparison of operation time, times of wiping the endoscopic lens, volume of postoperative drainage, and number of identified parathyroid gland between two groups.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fujian
      • Fuzhou, Fujian, China, 350001
        • Recruiting
        • Wen-xin ZHAO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients with maximum tumor diameter ≤1 cm;
  2. patients without lateral neck lymph node metastases;
  3. patients without distant metastases;
  4. patients who only needed unilateral surgery following the guidelines;
  5. patients with strong cosmetic requirement.

Exclusion criteria:

  1. Patients with maximum tumor diameter >1 cm;
  2. patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases;
  3. patients without cosmetic requirements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: foot-control exhaust group
The foot-control exhaust group used of the Pressure adjustable foot-control method by the way of adjustable Pressure to intermittent exhaust
Whether The Pressure adjustable foot-control method is used.
Placebo Comparator: direct exhaust group
direct exhaust group exhaust through the Trocar hole.and without use of the Pressure adjustable foot-control method
direct exhaust through the trocar.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flap separation time
Time Frame: 1 day after surgery
Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space.
1 day after surgery
Glandular excision time
Time Frame: 1 day after surgery
Glandular excision time was defined from incising cervical white line to removing Berry ligament.
1 day after surgery
Central lymph node dissection time
Time Frame: 1 day after surgery
Central lymph node dissection time: was from separating central lymph node to the specimen removed.
1 day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Times of wiping lens
Time Frame: 1 day after surgery
Times of wiping lens calculated from endoscopic video after operation was defined the times of wiping lens from endoscopy into the body to central lymph node removed.
1 day after surgery
Volume of intraoperative blood loss
Time Frame: 1 day after surgery
Volume of intraoperative blood loss was estimated the volume of intraoperative blood loss.
1 day after surgery
Volume of Postoperative drainage
Time Frame: 1 day,2 day,3 day after surgery
Volume of Postoperative drainage was accurately calculated the total volume while the drainage tube removed after operation.
1 day,2 day,3 day after surgery
The number of identifying parathyroid glands
Time Frame: 1 day after surgery
The number of identifying parathyroid glands was evaluated at postoperation while parathyroid glands was identified during surgery.
1 day after surgery
Blood PTH level
Time Frame: preoperative, first day after operation, one week after surgery, two months after surgery.
measurement of PTH level in blood
preoperative, first day after operation, one week after surgery, two months after surgery.
Blood calcium level
Time Frame: before surgery, the first day after surgery, one week after surgery, two months after surgery.
to measure the blood calcium level in the blood
before surgery, the first day after surgery, one week after surgery, two months after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

June 30, 2018

Study Completion (Anticipated)

December 30, 2018

Study Registration Dates

First Submitted

January 19, 2018

First Submitted That Met QC Criteria

January 25, 2018

First Posted (Actual)

January 26, 2018

Study Record Updates

Last Update Posted (Actual)

September 18, 2018

Last Update Submitted That Met QC Criteria

September 17, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endoscopy

Clinical Trials on used of the Pressure adjustable foot-control method

3
Subscribe